Atlas Wealth »

Provectus Biopharmaceuticals I shares owned by Atlas Wealth

Quarter-by-quarter ownership of Provectus Biopharmaceuticals I (PVCT) shares owned by Atlas Wealth from 13F filings

Historical chart of Atlas Wealth investment in Provectus Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Provectus Biopharmaceuticals I held by Atlas Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Provectus Biopharmaceuticals I by Atlas Wealth

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.4M 27k 127.31
2024-03-31 $4.9k 27k 0.18
2023-12-31 $2.2k 27k 0.08
2023-09-30 $2.2M 27k 84.49
2023-06-30 $3.1M 27k 114.80
2023-03-31 $4.4M 27k 164.99
2022-12-31 $2.9k 27k 0.11

More positions owned by Atlas Wealth

Srh Total Return Fund Incorporated Closed End Funds - Taxable (STEW)
Adams Diversified Equity Closed End Funds - Taxable (ADX)
Central Secs Corporation Closed End Funds - Taxable (CET)
U.s. Bancorp Pfd B Preferred Stock (USB.PH)
Blackstone Strategic Cred 2027 Com Shs Ben In Closed End Funds - Taxable (BGB)
Miller Howard High Inc Eqty Fd Com Shs Ben In Closed End Funds - Taxable (HIE)
Apple Incorporated Common Stock (AAPL)
General Amern Invs Company Incorporated Closed End Funds - Taxable (GAM)
Bank Of America Corporation Pfd 1/1200ser2 Preferred Stock (BML.PH)
Procter And Gamble Company Common Stock (PG)
Microsoft Corporation Common Stock (MSFT)
Pioneer Mun High Income Opport Closed End Investment Co. Non Tax Dividend (MIO)
Blackrock Cap Allocation Term Closed End Funds - Taxable (BCAT)
Nuveen Preferred & Income Term Closed End Funds - Taxable (JPI)
Ecofin Sustainable And Social Com Sh Ben Int Closed End Funds - Taxable (TEAF)

View all positions for Atlas Wealth

Top funds holding Provectus Biopharmaceuticals I

Home Federal Bank Of Tennessee
Lee, Danner & Bass
Atlas Wealth
Academy Capital Management
LBMC Investment Advisors
Financial Symmetry
Huntington National Bank

View all funds holding Provectus Biopharmaceuticals I